Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 31, 2024
Toxicity in patients receiving radiotherapy for ultracentral stage I non-small cell lung cancer: A secondary analysis of the LUSTRE randomized trialChe Hsuan David Wu, Marcin Wierzbicki, Sameer Parpia, et al.
Clinical and Translational Radiation Oncology|October 24, 2022
Lung SBRT credentialing in the Canadian OCOG-LUSTRE randomized trialAnand Swaminath, Marcin Wierzbicki, Sameer Parpia, et al.
Clinical Lung Cancer|November 24, 2016
Canadian Phase III Randomized Trial of Stereotactic Body Radiotherapy Versus Conventionally Hypofractionated Radiotherapy for Stage I, Medically Inoperable Non-Small-Cell Lung Cancer - Rationale and Protocol Design for the Ontario Clinical Oncology Group (OCOG)-LUSTRE TrialAnand Swaminath, Marcin Wierzbicki, Sameer Parpia, et al.
JAMA Oncology|September 19, 2024
Stereotactic vs Hypofractionated Radiotherapy for Inoperable Stage I Non-Small Cell Lung Cancer: The LUSTRE Phase 3 Randomized Clinical TrialAnand Swaminath, Sameer Parpia, Marcin Wierzbicki, et al.
Cancers|July 2, 2021
A Comparison of Hypofractionated and Twice-Daily Thoracic Irradiation in Limited-Stage Small-Cell Lung Cancer: An Overlap-Weighted AnalysisMichael Yan, Samantha Sigurdson, Noah Greifer, et al.
International Journal of Radiation Oncology, Biology, Physics|November 23, 2025
Quality of Life of Stereotactic Versus Hypofractionated Radiation Therapy for Inoperable Stage I Non-Small Cell Lung Cancer: Results From the LUSTRE TrialQirui Hou, Sameer Parpia, Marcin Wierzbicki, et al.
Annals of Surgery|January 24, 2020
How to Handle Arterial Conduits in Liver Transplantation? Evidence From the First Multicenter Risk AnalysisChristian E Oberkofler, Dimitri A Raptis, Joseph DiNorcia, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 23, 2022
Low-dose aspirin confers protection against acute cellular allograft rejection after primary liver transplantationChristian E Oberkofler, Dimitri A Raptis, Philip C Müller, et al.
Pageof 2